Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide and Organ-Specific Biological Aging
NCT07906041Phase 2Enrolling by invitation
- Sponsor
- Atria Research and Global Health Institute
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in biological aging, sponsored by Atria Research and Global Health Institute. Started Oct 2026; status: enrolling by invitation.
02
Drugs
03
Conditions
biological aging
Beyond the preview
Go deeper on NCT07906041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07906041.